Keywords
Quality of life
Hematopoietic cell transplantation
Adults
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To identify, analyze, and describe the impacts on the quality of life of adults after Hematopoietic Stem Cell Transplantation (HSCT). Methods: This is an integrative literature review study. The bibliographic survey was carried out in September 2024, using controlled descriptors and Boolean operators AND and OR to promote the search strategy in the LILACS, SCIELO/BVS, and PubMed databases. A total of 2,693 articles were found and, according to the inclusion criteria, 10 were selected for this study. This study was organized into three categories of well-being: physical, social, and psychological. Results: Physical well-being includes challenges such as cognitive decline and malnutrition after HSCT. In the social aspect, social support before and after transplantation proved to be crucial for quality of life. In psychological terms, factors such as self-efficacy and regret impacted the quality of life of survivors, highlighting the importance of interventions to improve post-transplant outcomes. Conclusion: It is concluded that HSCT affects physical, emotional and social aspects, such as pain, fatigue and isolation. Psychological, social and family support is essential to improve quality of life and facilitate patients' adaptation after treatment.
References
ABREU e MAURO HNG, et al. Análise socieodemográfica e clínica de pacientes submetidos ao transplante alogênico de células-troncos hematopoiéticas. Pesq Bras Odontoped Clin Integr, 2012; 12(3): 345-50.
ACS. CANCER FACTS AND FIGURES. 2022. American Cancer Society, 2022. Disponível em: https ://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-fac ts-and-figures/20 22/2022-cancer-facts-and-figures.pdf. Acessado em: 25 nov. 2024.
AMONOO e HERMIONI L, et al. Sharing and caring: The impact of social support on quality of life and health outcomes in hematopoietic stem cell transplantation. Cancer, 2021; 127(8): 1260-1265.
BRASIL. Transplante de medula óssea. 2023. Disponível em: https ://www.gov.br/inca/pt-br/as suntos/cancer/tratamento/transplante-de-medula-ossea. Acessado em: 03 out. 2024.
BRASIL. Tratamento do câncer. 2021. Disponível em: https ://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/c/cancer/tratamento. Acessado em: 03 out. 2024.
BRICE L, et al. Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all? Support Care Cancer, 2017; 25(2): 421-7.
BUCHBINDER, et al. Neurocognitive dysfunction in hematopoietic cell transplant recipients: Expert review from the late effects and Quality of Life Working Committee of the CIBMTR and Complications and Quality of Life Working Party of the EBMT. Bone Marrow Transplant, 2018; 53(5): 535-55.
CIOCE e MARCO ET al. Nutritional status and quality of life in adults undergoing allogeneic hematopoietic stem cell transplantation. International journal of hematology, 2022; 116(2): 266-275.
FARHDFAR, et al. Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors. Transplantation and Cellular Therapy, 2022; 28(9): 606-1606-8.
FERREL BR, et al. The meaning of quality of life for bone marrow transplant survivors. Part 1. The impact of bone marrow transplant on quality of life. Cancer Nursing, 1992; 15(3): 153-160.
FUNKE VAM, et al. Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantation. Rev. Assoc. Med. Bras., 2016; 62(1): 44-50.
JIM e HEATHER SL, et al. Perturbação do sono em receptores de transplante de células hematopoiéticas: prevalência, gravidade e tratamento clínico. Transplante de Medula Sanguínea Biol, 2014; 20(10): 1465-84.
KHERA S e KARACAN Y. Problemas fisiológicos em pacientes submetidos a transplante autólogo e alogênico de células-tronco hematopoiéticas. Ásia Pac J Oncol Nurs, 2014; 1(1): 50-4.
LU YIN, et al. Patient-reported physical well-being predicts good long-term survival of hematopoietic stem cell transplantation. Cancer Medicine, 2024; 13(13): 7409.
MACHADO e CELINA AM, et al. Quality of life and changes in the social dimension of hematopoietic stem cell transplants recipients. Revista Brasileira de Enfermagem, 2021; 74(1): 20200644.
MACRIS PC e MCMILLEN KK. Nutrition Support of the Hematopoietic Cell Transplant Recipient. In: FORMAN, SJ, et al. Thomas’ Hematopoietic Cell Transplantation: Stem Cell Transplantation. Wiley-Blackwell; 2016; 5: 1177-85.
MAGEDANZ e LEAL JVO, et al. Transplante de células-tronco hematopoiéticas: iniquidades na distribuição em território brasileiro, 2001 a 2020. Ciência e Saúde Coletiva, 2022; 27(8): 3239–47.
MAYO S, et al. Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation. Bone marrow transplant, 2016; 51(6): 841-7.
MCERLEAN e GEMMA, et al. Decisional Regret in Long-Term Australian Allogeneic Hematopoietic Stem Cell Transplantation Survivors: A Cross-Sectional Survey. Clinical Nursing Research, 2023; 32(8): 1134-1144.
MCGOWAN JV, et al. Anthracycline chemotherapy and cardiotoxicity. Cardiovasc Drugs Ther, 2017; 31(1): 63-75.
MOHRIN M. Mito-managing ROS & redox to reboot the immune system: Tapping mitochondria & redox management to extend the reach of hematopoietic stem cell transplantation. Free Radic Biol Med, 2021; 165: 38-53.
ROCHA, et al. Comprometimento social de pacientes submetidos ao transplante de células-tronco hematopoéticas. Rev Bras Enferm, 2016; 69(3): 484–91.
SAHIN U, et al. An overview of infectious complications after allogeneic hematopoietic stem cell transplantation. J Infect Chemother, 2016; 22(8): 505-14.
SANTOS e MARIA C, et al. Estudo sobre qualidade de vida com pacientes pós-TMO: aplicação do questionário WHOQOL-Bref. Mundo Saúde, 2008; 32(2): 146-56.
SOUZA MT, et al. Revisão integrativa: o que é e como fazer. Einstein, 2010; 8(1-1): 102-6.
TSATSOU I e MYSTAKIDOU K, et al. Sexuality and quality of life of patients with hematologic malignancy and hematopoietic stem cell transplantation: a critical review. J BUON, 2020; 25(4): 1693-1706.
WHO. Cancer today: Estimated number of prevalent cases in 2020, worldwide, both sexes, all ages (excl. NMSC). 2020. Disponível em: https ://gco.iarc.fr/today/online-analysistable?v=2020&mode=cancer& mod e_population=continents&population=900&populations=900&key=asr&sex=0&cancer=39&type=2&statistic=5 &prevalence=1&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&group_cancer=0&i nclude_nmsc=0&include_nmsc_other=1. Acessado em: 04 out. 2024.
WU e LISA M, et al. A mixed methods analysis of perceived cognitive impairment in hematopoietic stem cell transplant survivors. Palliative & Supportive Care, 2019; 17(4): 396-402.
WU e NATALIE L, et al. Long-term patient-reported neurocognitive outcomes in adult survivors of hematopoietic cell transplant. Blood Advances, 2022; 6(14): 4347-4356.
YU e JINGBO, et al. Patient-reported symptom burden and impact on daily activities in chronic graft-versus-host disease. Cancer Medicine, 2023; 12(3): 3623-3633.